| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/06/2002 | WO2002044319A2 Spatially directed ejection of cells from a carrier fluid |
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044201A2 Haplotypes of the sah gene |
| 06/06/2002 | WO2002044200A2 Haplotypes of the edg1 gene |
| 06/06/2002 | WO2002044198A2 Haplotypes of the slc1a4 gene |
| 06/06/2002 | WO2002044195A2 Method for base sequencing and biologically active nucleic acids |
| 06/06/2002 | WO2002043870A1 Microsystem for the dielectric and optical manipulation of particles |
| 06/06/2002 | WO2002043828A2 Microtiter plate format device and methods for separating differently charged molecules using an electric field |
| 06/06/2002 | WO2002043758A2 Uses of mammalian genes and related reagents |
| 06/06/2002 | WO2002043741A2 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | WO2002043615A2 Microfabricated elastomeric valve and pump systems |
| 06/06/2002 | WO2002043572A2 Erythropoietin and erythropoietin receptor expression in human cancer |
| 06/06/2002 | WO2002043559A2 Methods and kits for diagnosis of schizophrenia |
| 06/06/2002 | WO2002024941A3 Protein kinase regulation |
| 06/06/2002 | WO2002022652A3 Haplotypes of the slc18a2 gene |
| 06/06/2002 | WO2002020435A3 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 06/06/2002 | WO2002015770A3 Methods of cancer prognosis and assessment |
| 06/06/2002 | WO2002010764A3 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY |
| 06/06/2002 | WO2002006510A3 Photoselection of nucleic acid ligands |
| 06/06/2002 | WO2002006446A3 Haplotypes of the edg6 gene |
| 06/06/2002 | WO2001098456A3 IDENTIFICATION OF cDNAs ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA |
| 06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 06/06/2002 | WO2001094528A3 Visual-servoing optical microscopy |
| 06/06/2002 | WO2001094363A3 Haplotypes of the pfkfb2 gene |
| 06/06/2002 | WO2001092524A3 Myosin-like gene expressed in human heart and muscle |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001083732A3 Databases of regulatory sequences; methods of making and using same |
| 06/06/2002 | WO2001079542A3 Hiv detection assay and reagents therefor |
| 06/06/2002 | WO2001077668A3 Proteomic analysis using active-site directed probes |
| 06/06/2002 | WO2001077300A3 Human pancreatic epithelial progenitor cells and methods of isolation and use thereof |
| 06/06/2002 | WO2001075453A3 Methods involving induced dimerisation by cellular components |
| 06/06/2002 | WO2001067129A3 Epoxide polymer surfaces |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001051652A3 Method for identifying a mark applied on a solid body |
| 06/06/2002 | WO2001049886A3 Method of analyzing a nucleic acid |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001046472A3 Analysis of nucleotide polymorphisms at a site |
| 06/06/2002 | WO2001044516A3 Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay |
| 06/06/2002 | WO2001042497A9 Monitoring oligonucleotide binding processes using chemiluminescence quenching |
| 06/06/2002 | WO2001040504A3 Methods and compositions for detecting nitroaromatic compounds |
| 06/06/2002 | WO2001036687A3 Simultaneous hybridization/priming for snp analysis |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001032922A3 Methods for detection of a target nucleic acid sequence |
| 06/06/2002 | WO2001023604A9 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 06/06/2002 | WO2000068429A3 Diagnosis of glaucoma |
| 06/06/2002 | WO2000022430A3 Neisseria genomic sequences and methods of their use |
| 06/06/2002 | US20020069429 Method for conferring herbicide, pest, or disease resistance in plant hosts |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020069033 Method for determining measurement error for gene expression microarrays |
| 06/06/2002 | US20020068860 Comprises glucose oxidase emulsion with perfluorocarbon which is used with miniature polarographic device; gels |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068821 Separating nucleotide sequences from sample; obtain samples, form complexes, recover nucleotide sequences |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068707 Iga nephropathy-related genes |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
| 06/06/2002 | US20020068364 Apparatus for use in the detection of ammonia preferential surfaces |
| 06/06/2002 | US20020068363 Enhancing cell competence by recursive sequence recombination |
| 06/06/2002 | US20020068361 Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068347 Membrane protein for use in the diagnosis and prevention of cancer |
| 06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068340 Combinatorial enzyme development |
| 06/06/2002 | US20020068334 Multiplex amplification and separation of nucleic acid sequences using ligation-dependant strand displacement amplification and bioelectronic chip technology |
| 06/06/2002 | US20020068333 Generating preferential nucleotide sequences; obtain nucleic acids, clone into vector, detect and recover overlapping clones, sequence clones |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068314 Method of detecting mycobacteria |
| 06/06/2002 | US20020068313 Methods of diagnosing and treating crohn's disease using pseudomonas antigens |
| 06/06/2002 | US20020068311 Determination concentration of bicarbonate ion in solution using phosphenolpyruvate carboxylase and malate dehydrogenase; obtain sample, incubate with enzymes, detect signal from substrate |
| 06/06/2002 | US20020068310 Method and reagant for quantitative determination of 1,5-anhydroglucitol |
| 06/06/2002 | US20020068309 ATP extraction method |
| 06/06/2002 | US20020068308 Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents |
| 06/06/2002 | US20020068307 Compositions and methods for diagnosing, monitoring, staging, imaging and treating stomach cancer |
| 06/06/2002 | US20020068305 Detecting modulators of intergin binding activity; obtain cell that expresses preferential integrin, incubate with modulator, monitor cells for reduction in binding activity |
| 06/06/2002 | US20020068301 Cyclic peptide libraries and methods of use thereof to identify binding motifs |
| 06/06/2002 | US20020068300 Monitoring activity of modulators of weight regulatory protein; obtain sample, incubate with modulator, monitor activity of sample, adjustment in activity of regulatory protein indicates modulator |
| 06/06/2002 | US20020068299 Solid supports for use in the detection of preferential particles in sample |
| 06/06/2002 | US20020068298 Methods of identifying compounds that bind to target species under isothermal denaturing conditions |
| 06/06/2002 | US20020068297 Detecting and quantitating mouse lymphocytes receptor; obtain sample, incubate with primers, amplify sequences, detect dissasociated label |
| 06/06/2002 | US20020068296 Preventing oxidation of preferential nucleotide sequences; obtain nucleotide sequence, join to reducing agent, monitor activity of nucleotide sequences |
| 06/06/2002 | US20020068294 Probe for detecting a highly ordered structural site of a single stranded nucleic acid of a gene, and a method and a device for detecting the same |
| 06/06/2002 | US20020068293 Arrays having background features and methods for using the same |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068282 Dry detection preferential nucleotide sequences; obain sample, incubate with probe, detect signal from probe |
| 06/06/2002 | US20020068281 Novel, prostate-specific gene for diagnosis, prognosis and management of prostate cancer |
| 06/06/2002 | US20020068280 Isolating nucleotide sequences; obtain blood, lyse, remove leukocytes, lyse, extract nucleotide sequences, precipitate proteins, resuspend nucleotide sequences in solution |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068277 Evaluating open reading frames of preferential eukaryotic and prokaryotic organisms; obtain ribonucleic acid sequences, generate single sranded nucleotide sequences, amplify, deterimine seqence |
| 06/06/2002 | US20020068275 Nucleotides for use as tools in sequencing and nucleotide sequence amplification and sequencing |
| 06/06/2002 | US20020068273 Mimetics and inhibitors of the interaction between Vpr (HIV vIral protein of regulation) and ANT (mitochondrial adenine nucleotide translocator) |
| 06/06/2002 | US20020068272 Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
| 06/06/2002 | US20020068271 Methods for identifying agents capable of modulating protein kinase C theta (PKC0) activity |
| 06/06/2002 | US20020068270 Assessment of intracellular cysteine and glutathione concentrations |